Tomasz Chorągiewicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tomasz Chorągiewicz has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Robert Rejdak
Department of General and Pediatric Ophthalmology, Medical University of Lublin, Chmielna 1, 20-079 Lublin, Poland
6 shared publications - Joanna Dolar-Szczasny
Department of General and Paediatric Ophthalmology, Medical University of Lublin, Chmielna 1 Str., 20-079 Lublin, Poland
3 shared publications - Adam Słoka
Provincial Eye Hospital in Krakow, 31-723 Krakow, Poland
2 shared publications - Dominika Kuźmiuk
Student Scientific Club at the Department and Clinic of General and Paediatric Ophthalmology, Medical University of Lublin, Chmielna 1 Str., 20-079 Lublin, Poland
2 shared publications - Maria Kiełbus
Medical University of Lublin, Poland
2 shared publications - Mario Damiano Toro
Eye Clinic, Department of Public Health, University of Naples Federico II, 80131 Naples, Italy
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wydawnictwo Naukowe Gabriel Borowski (WNGB) in Advances in Science and Technology Research Journal
- Vol. 20 (1) , 510-524
Artificial intelligence: Assisted fundus image analysis for medical diagnostics in conflict zones
Artificial intelligence (AI) has become an important tool for recognizing changes in the ocular fundus, but most existing studies are conducted in peacetime clinical environments with advanced diagnostic equipment and stable infrastructure. In contrast, wartime conditions impose severe...
- 1 January 2026
- Published by Wydawnictwo Naukowe Gabriel Borowski (WNGB) in Advances in Science and Technology Research Journal
- Vol. 20 (1) , 510-524
Open AccessArtificial intelligence: Assisted fundus image analysis for medical diagnostics in conflict zones
Artificial intelligence (AI) has become an important tool for recognizing changes in the ocular fundus, but most existing studies are conducted in peacetime clinical environments with advanced diagnostic equipment and stable infrastructure. In contrast, wartime conditions impose severe...
- Open Access
- 1 December 2025
- Published by Wydawnictwo Naukowe Gabriel Borowski (WNGB) in Advances in Science and Technology Research Journal
- Vol. 19 (12) , 257-272
Keratoconus diagnosis based on dynamic corneal imaging using 3D convolutional neural networks
Keratoconus is a progressive disease that requires precise and rapid diagnosis, as well as the initiation of treatment, to prevent serious and permanent visual impairment. This article presents a comparison of 3D convolutional neural network models for the diagnosis of keratoconus based on...
- 1 December 2025
- Published by Wydawnictwo Naukowe Gabriel Borowski (WNGB) in Advances in Science and Technology Research Journal
- Vol. 19 (12) , 257-272
Open AccessKeratoconus diagnosis based on dynamic corneal imaging using 3D convolutional neural networks
Keratoconus is a progressive disease that requires precise and rapid diagnosis, as well as the initiation of treatment, to prevent serious and permanent visual impairment. This article presents a comparison of 3D convolutional neural network models for the diagnosis of keratoconus based on...
- Open Access
- 16 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (20) , 7309
Anatomical and Functional Outcomes of Sutureless Scleral-Fixated Carlevale Intraocular Lens Implantation: A Retrospective Study
Background/Objectives: The purpose of this study was evaluation of the efficacy and the rate of complication of a foldable sutureless scleral-fixated intraocular lens (SSF-IOL), named Carlevale IOL, for the treatment of aphakia without sufficient capsular support due to trauma or complicated cataract surgery. Methods: Retrospective, consecutive interventional case series. All consecutive eyes with secondary implantation of aphakic SSF-IOL were considered. The primary outcomes were as follows: best corrected visual acuity (BCVA), refractive error (RE), and intraocular pressure (IOP). Secondary outcome was the occurrence of intraoperative and postoperative complications. Results: SSF-IOL was performed in 21 eyes of 21 patients (7 men and 14 women) with mean age of 74 years (range from 36 to 90 years). The mean follow-up time was 11.4 months. VA improved significantly (p = 0.0007) from 0.38 logMAR at baseline to 0.11 logMAR at the final follow-up. BCVA improved in 18 patients, remained equal in 2 cases, and worsened in 1 case. Mean postoperative RE was −0.83 Diopters (D) (Median = −0.50 D, SD = 1.05 D) and it was less than 1D in 61.9% of patients. Mean IOP at the end of the follow-up was 15.78 mmHg (ranged from 10 to 22 mmHg, SD = 3.65). In one patient a vitreous hemorrhage was observed intraoperatively, but it resolved spontaneously. Postoperative complications included one case of cystoid macular edema and one case of epiretinal membrane. Conclusions: Carlevale SSF-IOL implantation seems to be an effective and safe procedure, ensuring good visual outcomes with a low rate of complication in eyes indicated for secondary IOL implantation.
- 16 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (20) , 7309
Open AccessAnatomical and Functional Outcomes of Sutureless Scleral-Fixated Carlevale Intraocular Lens Implantation: A Retrospective Study
Background/Objectives: The purpose of this study was evaluation of the efficacy and the rate of complication of a foldable sutureless scleral-fixated intraocular lens (SSF-IOL), named Carlevale IOL, for the treatment of aphakia without sufficient capsular support due to trauma or complicated cataract surgery. Methods: Retrospective, consecutive interventional case series. All consecutive eyes with secondary implantation of aphakic SSF-IOL were considered. The primary outcomes were as follows: best corrected visual acuity (BCVA), refractive error (RE), and intraocular pressure (IOP). Secondary outcome was the occurrence of intraoperative and postoperative complications. Results: SSF-IOL was performed in 21 eyes of 21 patients (7 men and 14 women) with mean age of 74 years (range from 36 to 90 years). The mean follow-up time was 11.4 months. VA improved significantly (p = 0.0007) from 0.38 logMAR at baseline to 0.11 logMAR at the final follow-up. BCVA improved in 18 patients, remained equal in 2 cases, and worsened in 1 case. Mean postoperative RE was −0.83 Diopters (D) (Median = −0.50 D, SD = 1.05 D) and it was less than 1D in 61.9% of patients. Mean IOP at the end of the follow-up was 15.78 mmHg (ranged from 10 to 22 mmHg, SD = 3.65). In one patient a vitreous hemorrhage was observed intraoperatively, but it resolved spontaneously. Postoperative complications included one case of cystoid macular edema and one case of epiretinal membrane. Conclusions: Carlevale SSF-IOL implantation seems to be an effective and safe procedure, ensuring good visual outcomes with a low rate of complication in eyes indicated for secondary IOL implantation.
- Open Access
- 16 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (16) , 7906
The Supportive Role of Plant-Based Substances in AMD Treatment and Their Potential
There is growing interest in the use of natural plant-derived compounds, such as polyphenols (including curcumin), flavonoids, silymarin, anthocyanins, lutein, and zeaxanthin, for the treatment of age-related macular degeneration (AMD). These substances exhibit antioxidant, anti-inflammatory, and protective effects on retinal cells, contributing to the preservation of retinal integrity by modulating the key pathogenic mechanisms of AMD, including oxidative stress, chronic inflammation, and pathological neovascularization. Consequently, they hold potential to support conventional therapeutic approaches and slow disease progression. Current studies highlight their promising role as adjunctive agents in AMD management. This literature review provides a comprehensive analysis of the potential role of the aforementioned natural plant-derived compounds in the prevention and supportive treatment of age-related macular degeneration. It also discusses their natural sources, modes of administration and supplementation, and highlights the importance of a nutrient-rich diet as a key factor in maintaining ocular health. Furthermore, the review synthesizes current scientific knowledge on the ability of natural antioxidants to slow the progression of AMD and outlines future research directions aimed at improving diagnostic methods and developing more effective preventive and therapeutic strategies.
- 16 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (16) , 7906
Open AccessThe Supportive Role of Plant-Based Substances in AMD Treatment and Their Potential
There is growing interest in the use of natural plant-derived compounds, such as polyphenols (including curcumin), flavonoids, silymarin, anthocyanins, lutein, and zeaxanthin, for the treatment of age-related macular degeneration (AMD). These substances exhibit antioxidant, anti-inflammatory, and protective effects on retinal cells, contributing to the preservation of retinal integrity by modulating the key pathogenic mechanisms of AMD, including oxidative stress, chronic inflammation, and pathological neovascularization. Consequently, they hold potential to support conventional therapeutic approaches and slow disease progression. Current studies highlight their promising role as adjunctive agents in AMD management. This literature review provides a comprehensive analysis of the potential role of the aforementioned natural plant-derived compounds in the prevention and supportive treatment of age-related macular degeneration. It also discusses their natural sources, modes of administration and supplementation, and highlights the importance of a nutrient-rich diet as a key factor in maintaining ocular health. Furthermore, the review synthesizes current scientific knowledge on the ability of natural antioxidants to slow the progression of AMD and outlines future research directions aimed at improving diagnostic methods and developing more effective preventive and therapeutic strategies.
- Open Access
- 7 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (15) , 5579
Sympathetic Ophthalmia as a Complication of Untreated Choroidal Melanoma
We present a rare case of sympathetic ophthalmia in the fellow eye of a 59-year-old Caucasian male diagnosed with untreated malignant choroidal melanoma. Initially identified with a medium-sized choroidal melanoma, the patient declined recommended brachytherapy and did not seek medical attention for two years. Upon returning, he exhibited signs of sympathetic ophthalmia in the contralateral eye. Treatment with corticosteroid-based immunosuppression was initiated. After consenting to treatment for the melanoma, the affected left eye was enucleated, and histopathology confirmed spindle cell choroidal melanoma. This case underscores the uncommon development of sympathetic ophthalmia without prior ocular trauma or surgery, linked to untreated choroidal melanoma.
- 7 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (15) , 5579
Open AccessSympathetic Ophthalmia as a Complication of Untreated Choroidal Melanoma
We present a rare case of sympathetic ophthalmia in the fellow eye of a 59-year-old Caucasian male diagnosed with untreated malignant choroidal melanoma. Initially identified with a medium-sized choroidal melanoma, the patient declined recommended brachytherapy and did not seek medical attention for two years. Upon returning, he exhibited signs of sympathetic ophthalmia in the contralateral eye. Treatment with corticosteroid-based immunosuppression was initiated. After consenting to treatment for the melanoma, the affected left eye was enucleated, and histopathology confirmed spindle cell choroidal melanoma. This case underscores the uncommon development of sympathetic ophthalmia without prior ocular trauma or surgery, linked to untreated choroidal melanoma.
- Open Access
- 28 March 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (7) , 3129
Changes in the Protein Composition of the Aqueous Humor in Patients with Glaucoma: An Update Review
The study of the aqueous humor (AH) plays a key role in understanding the pathophysiology of glaucoma. The AH provides nutrition, maintains the appropriate intraocular pressure, and provides important information about the mechanisms of the disease. The development of modern technologies has allowed the use of more accurate analytical methods, which has proven to be a key factor in determining the changes occurring in the proteome of the aqueous humor of glaucoma patients. Recently, researchers have observed changes in the levels of proteins associated with inflammation, oxidative stress, the complement system, and extracellular matrix remodeling. They have also shown that these changes may be variable for different types of glaucoma. The objective of this review is to collect and summarize the current knowledge on the potential biomarkers and pathomechanisms involved in the pathogenesis of glaucoma. We hope that our review will contribute to the improvement of current diagnostic methods in this illness and, through a better understanding of the changes occurring during the progression of the disease, will enable the development of more effective preventive and therapeutic strategies in the future.
- 28 March 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (7) , 3129
Open AccessChanges in the Protein Composition of the Aqueous Humor in Patients with Glaucoma: An Update Review
The study of the aqueous humor (AH) plays a key role in understanding the pathophysiology of glaucoma. The AH provides nutrition, maintains the appropriate intraocular pressure, and provides important information about the mechanisms of the disease. The development of modern technologies has allowed the use of more accurate analytical methods, which has proven to be a key factor in determining the changes occurring in the proteome of the aqueous humor of glaucoma patients. Recently, researchers have observed changes in the levels of proteins associated with inflammation, oxidative stress, the complement system, and extracellular matrix remodeling. They have also shown that these changes may be variable for different types of glaucoma. The objective of this review is to collect and summarize the current knowledge on the potential biomarkers and pathomechanisms involved in the pathogenesis of glaucoma. We hope that our review will contribute to the improvement of current diagnostic methods in this illness and, through a better understanding of the changes occurring during the progression of the disease, will enable the development of more effective preventive and therapeutic strategies in the future.